Brief: Cns Pharmaceuticals Says GMP Manufacturer Partner Got Certificate Of Analysis For Active Pharma Ingredient
01/10/2020 14:44
Oct 1 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS - CO'S GMP MANUFACTURER PARTNER GOT
CERTIFICATE OF ANALYSIS FOR ACTIVE PHARMA INGREDIENT, CLEARING
FOR USE IN BERUBICIN PRODUCTION
* CNS PHARMACEUTICALS - LOOK FORWARD TO INITIATING U.S.
PHASE 2
TRIAL IN Q1 OF 2021
Source text for Eikon: ID:nPn2zPJLwa
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026